Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma

Clinical trial NCT06370871 · WITHDRAWN

Trial details

NCT number: NCT06370871
Sponsor: Boehringer Ingelheim
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Soft Tissue Sarcoma Undifferentiated Pleomorphic Sarcoma (UPS)Myxofibrosarcoma (MFS)

Start date: 2024-06-27
Primary completion: 2026-07-03
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.